Mara Cusker Gonzalez

No Defect, No Duty: California Supreme Court Reaffirms The Bedrock Of Products Liability Law

340B Meets The FCA In The Ninth Circuit: What The Pharmaceutical Industry And Investors Need To Know OnPoint Thu Sep 03 2026 The Ninth Circuit's Adventist Decision Lets 340B Covered Entities Bring FCA Qui Tam Suits Over Drug Pricing, Raising New Risks For Manufacturers And Investors.

Standing And Preemption Deliver Early Dismissals In Toothpaste Heavy Metals Class Action

U.S. Supreme Court Rules FIFRA Expressly Preempts State Failure-to-Warn Claims In Roundup Litigation

Maryland Supreme Court Rejects Opioid And Climate Change Nuisance Cases

New Manual On Scientific Evidence Offers Updated Rule 702 Roadmap For Courts

No Waiver Here: Courts Protect Consumer Arbitration Rights And Sanction Counsel For Misrepresentation

California Governor Vetoes PFAS Phaseout For Cookware And Consumer Goods

GLP-1 MDL Requires Objective Testing To Proceed

EKRA Heats Up: What U.S. Laboratories And Investors Need To Know

Are Automakers Liable For Crime-Driven Costs? Ninth Circuit Certifies Question To New York High Court

Fourth Circuit To Decide Opioids Public Nuisance Appeal After West Virginia's Highest Court Declines Certified Question

Cert Petition Asks Supreme Court to Reject "Heavy Albrecht" Preemption Standard

Labcorp v. Davis: Will The Supreme Court Finally Address Uninjured Class Members?

U.S. Supreme Court Holds RICO Does Not Bar Economic Damages Stemming From Personal Injury

Medical Monitoring Class Action Based On Mere Exposure To Lead Fails For Lack Of Standing

State Court Appeals To Watch In 2025